Utility of targeted sonography for breast lesions that were suspicious on MRI

American Journal of Roentgenology

Volumn 192, Issue 4, 2009, Pages 1128-1134

  Demartini, Wendy B ^a,b   Eby, Peter R ^a,b   Peacock, Sue ^a,b   Lehman, Constance D ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b SEATTLE CANCER CARE ALLIANCE   (United States)

Author keywords

Breast MRI; Lesion detection; Malignancy; Sonography

Indexed keywords

GADODIAMIDE;

ADULT; AGED; ARTICLE; BENIGN TUMOR; BREAST BIOPSY; BREAST CANCER; BREAST LESION; BREAST TUMOR; CLINICAL FEATURE; COMPARATIVE STUDY; DATA BASE; ECHOMAMMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ENHANCEMENT; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCULT CANCER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; RETROSPECTIVE STUDIES; ULTRASONOGRAPHY, MAMMARY;

EID: 63849290572     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.07.3987     Document Type: Article

References (42)

1. Kaiser WA, Zeitler E. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Radiology 1989; 170:681-686
2. Harms SE, Flamig DP, Hesley KL, et al. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 1993; 187:493-501
3. Boetes C, Barentsz JO, Mus RD, et al. MR characterization of suspicious breast lesions with a gadolinium enhanced turboFLASH subtraction technique. Radiology 1994; 193:777-781
4. Heywang-Kobrunner SH, Viehweg P, Heinig A,Kuchler C. Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. Eur J Radiol 1997; 24:94-108
5. Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis and staging of breast cancer. Radiology 2001; 220:13-30
6. Berg WA, Gutierrez L, NessAiver MS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 2004; 233:830-849
7. Bedrosian I, Mick R, Orel SG, et al. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer 2003; 98:468-473
8. Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 1999; 213:881-888
9. Liberman L, Morris EA, Dershaw DD, Abramson AF, Tan LK. MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. AJR 2003; 180:901-910
10. Mumtaz H, Hall-Craggs MA, Davidson T, et al. Staging of symptomatic primary breast cancer with MR imaging. AJR 1997; 169:417-424
11. Orel SG, Schnall MD, Powell CM, et al. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology 1995; 196: 115-122
12. Schelfout K, Van Goethem M, Kersschot E, et al. Contrast-enhanced MR imaging of breast lesions and effect on treatment. Eur J Surg Oncol 2004; 30:501-507
13. Schnall MD, Blume J, Bluemke DA, et al. MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883. J Surg Oncol 2005; 92:32-38
14. Rieber A, Merkle E, Bohm W, Brambs HJ, Tom- czak R. MRI of histologically confirmed mammary carcinoma: clinical relevance of diagnostic procedures for detection of multifocal or contralateral secondary carcinoma. J Comput Assist Tomogr 1997; 21:773-779
15. Slanetz PJ, Edmister WB, Yeh ED, Talele AC, Ko-pans DB. Occult contralateral breast carcinoma incidentally detected by breast magnetic resonance imaging. Breast J 2002; 8:145-148
16. Liberman L, Morris EA, Kim CM, et al. MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR 2003; 180:333-341
17. Lee SG, Orel SG, Woo IJ, et al. MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results. Radiology 2003; 226:773-778
18. Viehweg P, Rotter K, Laniado M, et al. MR imaging of the contralateral breast in patients after breast-conserving therapy. Eur Radiol 2004; 14: 402-408
19. Pediconi F, Venditti F, Padula S, et al. CE-magnetic resonance mammography for the evaluation of the contralateral breast in patients with diagnosed breast cancer. Radiol Med 2005; 110:61-68
20. Lehman CD, Blume JD, Thickman D, et al. Added cancer yield of MRI in screening the contral-ateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium(IBMC) trial. J Surg Oncol 2005; 92:9-15
21. Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 2005; 23:8469-8476
22. Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.JAMA 2004; 292:1317-1325
23. Podo F, Sardanelli F, Canese R, et al. The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. J Exp Clin Cancer Res 2002; 21:115-124
24. Tilanus-Linthorst MM, Obdeijn IM, Bartels KC, de Koning HJ, Oudkerk M. First experiences in screening women at high risk for breast cancer with MR imaging. Breast Cancer Res Treat 2000; 63:53-60
25. Morris EA, Liberman L, Ballon DJ, et al. MRI of occult breast carcinoma in a high-risk population. AJR 2003; 181:619-626
26. Kriege M, Brekelmans CT, Boetes C, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004; 351:427-437
27. Lehman CD, Blume JD, Weatherall P, et al. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer 2005; 103:1898-1905
28. Lehman CD, Isaacs C, Schnall MD, et al. Cancer yield of mammography, MRI, and ultrasound in high risk women: prospective multi-institution breast cancer screening study. Radiology 2007; 244:381-388
29. Leach MO, Boggis CR, Dixon AK, et al. Screening with magnetic resonance imaging and mam-mography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study(MARIBS). Lancet 2005; 365:1769-1778
30. Sardanelli F, Podo F, D'Agnolo G, et al. Multi- center comparative multimodality surveillance of women at genetic-familial high risk for breast cancer(HIBCRIT study): interim results. Radiology 2007; 242:698-715
31. Stomper PC, Waddell BE, Edge SB, Klippenstein DL. Breast MRI in the evaluation of patients with occult primary breast carcinoma. Breast J 1999; 5:230-234
32. Henry-Tillman RS, Harms SE, Westbrook KC, Korourian S, Klimberg VS. Role of breast magnetic resonance imaging in determining breast as a source of unknown metastatic lymphadenopa-thy. Am J Surg 1999; 178:496-500
33. Orel SG, Weinstein SP, Schnall MD, et al. Breast MR imaging in patients with axillary node metas-tases and unknown primary malignancy. Radiology 1999; 212:543-549
34. Obdeijn IM, Brouwers-Kuyper EM, Tilanus-Linthorst MM, Wiggers T, Oudkerk M. MR imag-ing-guided sonography followed by fine-needle aspiration cytology in occult carcinoma of the breast. AJR 2000; 174:1079-1084
35. Olson JA Jr, Morris EA, Van Zee KJ, Linehan DC, Borgen PI. Magnetic resonance imaging facilitates breast conservation for occult breast cancer. Ann Surg Oncol 2000; 7:411-415
36. Buchanan CL, Morris EA, Dorn PL, Borgen PI, Van Zee KJ. Utility of breast magnetic resonance imaging in patients with occult primary breast cancer. Ann Surg Oncol 2005; 12:1045-1053
37. Bassett LW, Dhaliwal SG, Eredat J, et al. National trends and practices in breast MRI. AJR 2008; 191:332-339
38. American College of Radiology. ACR BI-RADS: MRI. ACR breast imaging reporting and data system, breast imaging atlas. Reston, VA: American College of Radiology, 2003
39. LaTrenta LR, Menell JH, Morris EA, Abramson AF, Dershaw DD, Liberman L. Breast lesions detected with MR imaging: utility and histopatho-logic importance of identification with US. Radiology 2003; 227:856-861
40. Beran L, Liang W, Nims T, Paquelet J, Sickle-Santanello B. Correlation of targeted ultrasound with magnetic resonance imaging abnormalities of the breast. Am J Surg 2005; 190:592-594
41. Sim LS, Hendriks JH, Bult P, Fook-Chong SM. US correlation for MRI-detected breast lesions in women with familial risk of breast cancer. Clin Radiol 2005; 60:801-806
42. Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. AJR 2003; 181:51-55